Search Results
May 22, 2026, 09:15 ET Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock
intentional tort of wire fraud under 18 U.S.C. § 1343. Lunai seeks compensatory and special damages, injunctive relief, prejudgment and post-judgment interest, and recovery of costs and reasonable attorneys' fees. The defendants are identified in the complaint as Does 1-50, Roe Corporations
More news about: Lunai Bioworks Inc.
May 22, 2026, 09:06 ET Berger Montague PC Investigating Claims on Behalf of ChampionX Corporation (NASDAQ: CHX) Investors After Class Action Filing
complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law,
More news about: Berger Montague
May 22, 2026, 09:00 ET The Heavenly Xizang Themed Post Office: Sending a "Tibetan plateau time"
Heavenly Xizang Themed Post Office：Sending a "Tibetan plateau time"https://www.youtube.com/watch?v=K8QML2qkQH0The Heavenly Xizang Themed Post Office in Lhasa offers
More news about: China.org.cn
May 22, 2026, 08:55 ET NYSE Content Update: Spotify Shares Climb 13% Following Investor Day Event
Ashley Mastronardi delivers the pre-market update on May 22ndThe S&P 500 aims to post its eighth consecutive winning week as a new era begins for the Federal Reserve.Shares of Spotify (NYSE: SPOT) jumped by 13% Thursday after
More news about: New York Stock Exchange
May 22, 2026, 08:12 ET Korea University and Harbin Institute of Technology Unlock New Pathways in Circular Waste-to-Energy Solutions
shift, advocating for science-driven strategies that convert waste into critical materials, renewable energy, and economic value. In the context of post-pandemic recovery, his work highlights how circular economy principles are evolving into a key driver of industrial and environmental transformation.Plastic
More news about: Korea University and Harbin Institute of Technology
May 22, 2026, 08:00 ET AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
reported adverse reactions were fatigue (3%), asthenia (2%), headache (2%), and diarrhea (2%). No on-treatment virologic failures or post-treatment relapses were observed, and post-treatment reinfection occurred in 0.7% of patients.More information on the study can be found at
More news about: AbbVie
May 22, 2026, 08:00 ET Parker Institute for Cancer Immunotherapy Brings the Power of Its Integrated Network to ASCO 2026
low-, or high-dose preoperative radiation with pembrolizumab and chemotherapy in node-positive breast cancer (Abstract 1011, oral co-author).Post-NCIT Outcomes (Elizabeth Mittendorf, MD, PhD — Dana-Farber): Outcomes after recurrence on neoadjuvant chemo-immunotherapy in patients with
More news about: Parker Institute for Cancer Immunotherapy
May 22, 2026, 07:49 ET Eightco Holdings (NASDAQ: ORBS) rapporteert totale activa van ongeveer USD 333 miljoen, waaronder belangen in OpenAI, Beast Industries, meer dan 11.000 ETH en meer dan 283 miljoen WLD-tokens.
Washington Post)."OpenAI Deployment Co creëert Palantir-achtige forward deployment-mogelijkheden en een enorme bedrijfsdifferentiator in vergelijking
More news about: Eightco Holdings (NASDAQ: ORBS)
May 22, 2026, 06:02 ET 14 Press Releases You Need to See This Week
collection and exclusive merchandise will be available starting the first week of June. The lineup of treats specifically crafted for game-day energy and post-match celebrations includes Soccer Brownies, Soccer S'mores Mini Muffins, Soccer Gingerbread Cookies and Soccer Mini Donuts.Read more of
More news about: PR Newswire
May 21, 2026, 18:46 ET AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
A phase 2 randomized study comparing telisotuzumab adizutecan monotherapy with standard of care in patients with post-adjuvant circulating tumor DNA-positive colorectal cancer.
More news about: AbbVie
May 21, 2026, 18:03 ET Universal Technical Institute and Peloton Interactive Set to Join S&P SmallCap 600
PTON) will replace Enviri Corp. (NYSE: NVRI). Enviri is spinning off certain operations and assets later this month into a new publicly traded company. Post spin-off, Veolia Environment SA will acquire the remaining parent entity. The new publicly traded company is not expected to be representative of the
More news about: S&P Dow Jones Indices
May 21, 2026, 17:17 ET Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress
rate of 57% and a median response duration of 30.3 months. Substantial reductions in transfusion dependence further support olutasidenib as a viable post-venetoclax therapeutic option. These findings suggest that earlier sequencing of olutasidenib in the treatment paradigm may optimize patient outcomes.ASCO
More news about: Rigel Pharmaceuticals, Inc.
May 21, 2026, 17:00 ET Greenberg Traurig Bolsters Government Contracts and Space Practices with Shaun Kennedy in Denver
technology industries, helping them with complex government contracts needs, from pre-award counseling through post-award disputes and enforcement matters."Shaun is a talented government contracts lawyer, and his arrival is a major addition to the government
More news about: Greenberg Traurig, LLP
May 21, 2026, 17:00 ET Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026
Potential effects of TGF-β inhibition on immune resistance by targeting immunosuppressive microenvironment in advanced gastric cancer (AGC): Multi-omics post-hoc analysis of the K-Umbrella-06 Trial About LunitFounded in 2013, Lunit (KRX: 328130) is a global leader
More news about: Lunit
May 21, 2026, 17:00 ET Sapience Therapeutics Provides Positive Data Update from Phase 2 Trial of Lucicebtide Plus SOC in Patients with Glioblastoma at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
LinkedIn.1 Dhingra S, Koshy M, Korpics M. Limited survival benefit in patients diagnosed with glioblastoma post-2016: a SEER population based registry analysis. J Cancer Res Clin Oncol. 2025 Jun 2;151(6):179. doi: 10.1007/s00432-025-06171-4. PMID: 40455099; PMCID:
More news about: Sapience Therapeutics, Inc.
May 21, 2026, 17:00 ET Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio
of 1) adult patients with advanced or metastatic triple-negative breast cancer, and 2) advanced or metastatic HER2 low / HER2 negative breast cancer post-topo-1 ADC (including TNBC and certain HR+ breast cancers). It has also received Breakthrough Designation from the FDA for the treatment of patients
More news about: Servier Pharmaceuticals
May 21, 2026, 17:00 ET Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
included fever, rash and arthralgias or myalgias with concurrent decreased platelets or transaminitis. Stevens-Johnson Syndrome has been observed in the post-marketing setting. Discontinue Retevmo in patients with Stevens-Johnson Syndrome. If hypersensitivity occurs, withhold Retevmo and begin corticosteroids
More news about: Eli Lilly and Company
May 21, 2026, 16:09 ET Eightco Holdings (NASDAQ: ORBS) informa de que su cartera total asciende a unos 337 millones de dólares
Washington Post)."OpenAI Deployment Co crea capacidades de despliegue avanzado similares a las de Palantir y una enorme ventaja competitiva para las
More news about: Eightco Holdings (NASDAQ: ORBS)
May 21, 2026, 16:05 ET FLOWERS FOODS, INC. REPORTS FIRST QUARTER 2026 RESULTS
dollarsPre-Recorded Management Remarks and Question and Answer WebcastIn conjunction with this release, Flowers Foods will post pre-recorded management remarks and a supporting slide presentation on the investors page of flowersfoods.com. The company will host a live question
More news about: Flowers Foods, Inc.
May 21, 2026, 16:04 ET Maryland Stem Cell Research Commission Announces More Than $12.6 Million in Awards to Advance Regenerative Medicine and Opens Applications for Next Funding Cycle
Tampakakis, Vasiliki Machairaki, Chulan Kwon and Aaron James from Johns Hopkins University.Post-Doctoral Fellowship: These awards support exceptional post-doctoral fellows conducting research in Maryland. Totaling $1,300,000, award recipients include Dr. Sahar Vakili from
More news about: Maryland Stem Cell Research Commission
May 21, 2026, 15:45 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JetBlue Airways Corporation - JBLU
joining the class action]On April 18, 2026, in a post on X, a JetBlue customer expressed frustration about an apparently sudden increase in the price for a certain JetBlue plane ticket. JetBlue responded to the customer's post, suggesting that the customer "[t]ry clearing your cache and cookies
More news about: Pomerantz LLP
May 21, 2026, 15:30 ET Community Comes Together for Second Annual 'Wisdom Gallery' Opening in Rye, N.Y.
Rye Free Reading Room, 1061 Boston Post Road, Rye, through June. Visitors may explore the exhibit in person and access the online
More news about: The Osborn
May 21, 2026, 15:10 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LKQ Corporation of Class Action Lawsuit and Upcoming Deadlines - LKQ
business, including major customers, to LKQ's competitors. LKQ revealed that these losses began "pre-acquisition or pre-closing and leading into post-acquisition." Then, on April 24, 2025, LKQ revealed that its North American market segment, where FinishMaster was now fully integrated, had continued to
More news about: Pomerantz LLP
May 21, 2026, 15:10 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA
tabelecleucel (also referred to as tab-cel or EBVALLO), a T-cell immunotherapy program for the treatment of, inter alia, Epstein-Barr virus positive post-transplant lymphoproliferative disease ("EBV+ PTLD").Atara is partnered with Pierre Fabre Médicament, a subsidiary of the Pierre Fabre Laboratories
More news about: Pomerantz LLP
May 21, 2026, 14:56 ET Eightco Holdings (NASDAQ : ORBS) annonce un total d'environ 337 millions de dollars en avoirs, dont OpenAI, Beast Industries, plus de 11 000 ETH et plus de 283 millions de tokens WLD
Washington Post).« OpenAI Deployment Co crée des capacités de déploiement de type Palantir et un facteur de différenciation massif par rapport à ses concurrents »,
More news about: Eightco Holdings (NASDAQ: ORBS)